title: Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL Study 83.
authors.affiliation: Department of Hematology/Oncology, Free University of Berlin, Federal Republic of Germany.
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: H
authors.initials: H
authors.lastname: Seibt-Jung
authors.forename: J V
authors.initials: JV
authors.lastname: Teichmann
authors.forename: B
authors.initials: B
authors.lastname: Komischke
authors.forename: A
authors.initials: A
authors.lastname: Gatzke
authors.forename: G
authors.initials: G
authors.lastname: Gassner
authors.forename: E
authors.initials: E
authors.lastname: Odenwald
authors.forename: J
authors.initials: J
authors.lastname: Hofmann
authors.forename: H
authors.initials: H
authors.lastname: Riehm
mesh_terms: D000911:Antibodies, Monoclonal; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D015337:Multicenter Studies as Topic; D010641:Phenotype; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000276:immunology* / Q000401:mortality; D011379:Prognosis; D011446:Prospective Studies; D012074:Remission Induction; D015996:Survival Rate
chemical_list: D000911:Antibodies, Monoclonal